Alberto Bosi
Alberto Bosi publishes mostly in Hematology, Genetics and Oncology, on topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #786,111 of 7,710,434 ranked researchers
- Rank in Italy
- #23,730 of 242,206
- Works
- 652
- Citations
- 23k
- Citations per work
- 34.6
What does Alberto Bosi research?
Alberto Bosi's work is mostly in Medicine (54%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences34953.5%
- Medicine34953.5%
- Everything else23035.3%
- Life Sciences7311.2%
- 1Hematology28% of their works
- 2Genetics12% of their works
- 3Oncology8% of their works
- 4Molecular Biology7% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Immunology4% of their works
Research topics
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
Which keywords describe Alberto Bosi's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Rituximab, Minimal Residual Disease, Bone Marrow Niche, Graft-versus-Host Disease, Acute Myeloid Leukemia and AML.
- Genomic Aberrations
- Childhood Cancer
- International Myeloma Working Group
- Imatinib
- Lymphoma
- Myelofibrosis
- Acute Myeloid Leukemia
- Graft-versus-Host Disease
- Minimal Residual Disease
- Prognostic Factors
- Hematopoietic Stem Cells
- Rituximab
- Bone Marrow Niche
- AML
- JAK2 Mutation
- Classification
- BCR-ABL
- Diagnosis Criteria
- Acute Lymphoblastic Leukemia
- Chronic Lymphocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Hematopoietic Stem Cells2702 topics
- Prognostic Factors2513 topics
- Rituximab1512 topics
- Minimal Residual Disease1422 topics
- Bone Marrow Niche1401 topic
- Graft-versus-Host Disease1401 topic
- AML1301 topic
- Acute Myeloid Leukemia1301 topic
- JAK2 Mutation1051 topic
- Myelofibrosis1051 topic
- Classification911 topic
- Lymphoma911 topic
- BCR-ABL871 topic
- Imatinib871 topic
- Diagnosis Criteria811 topic
- International Myeloma Working Group811 topic
- Acute Lymphoblastic Leukemia611 topic
- Childhood Cancer611 topic
- Chronic Lymphocytic Leukemia601 topic
- Genomic Aberrations601 topic
Where does Alberto Bosi work?
Alberto Bosi's main affiliation in the publication record is University of Florence, Italy.
How many publications and citations does Alberto Bosi have?
OpenAlex counts 652 works and 22,566 citations for Alberto Bosi, an h-index of 80, ranking #786,111 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alberto Bosi. Posts are plain text and can be reported.